ERGO & ISARIC
The Epidemic diseases Research Group Oxford (ERGO, established in 2014) aims to reduce the health and socioeconomic impact of epidemic infections through patient-centred research and the development of methodological approaches suited to epidemic settings. The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC, part of ERGO) aims to prevent illness and deaths from infectious diseases outbreaks, by generating and disseminating clinical research evidence when infectious diseases outbreaks occur.
Led by Professor Peter Horby, the Epidemic diseases Research Group Oxford is engaged in an international programme of clinical and epidemiological research to prepare for and respond to emerging diseases that may turn into epidemics or pandemics, including Ebola, bird flu, MERS-CoV, and Enterovirus.
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is a global federation of clinical research networks that aims to generate and disseminate clinical research evidence whenever and wherever outbreak-prone infectious diseases occur.
ISARIC includes 56 networks with representation in more than 112 countries, across high, middle and low income resource settings. The consortium has the expertise and resources to provide a proficient, coordinated, and agile research response to outbreak-prone infectious diseases.
The ISARIC Global Support Centre is hosted by the Centre for Tropical Medicine and Global Health, and supports ISARIC members to prepare and respond to epidemics by offering a range of services – from scientific and technical support and standardization and harmonization, to project management, initiation, and design, networking and knowledge sharing, and research innovation.
ECRAID (European Clinical Research Alliance in Infectious Disease) interviews Professor Peter Horby:
If we want to prevent outbreaks, if we want to be able to diagnose them quickly, and if we want to develop vaccines, you have got to do clinical research.